Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 72,210,936
  • Shares Outstanding, K 447,792
  • Annual Sales, $ 9,256 M
  • Annual Income, $ 2,486 M
  • EBIT $ 3,274 M
  • EBITDA $ 3,771 M
  • 60-Month Beta 0.94
  • Price/Sales 7.74
  • Price/Cash Flow 22.64
  • Price/Book 15.14

Options Overview Details

View History
  • Implied Volatility 24.89% ( -1.70%)
  • Historical Volatility 32.01%
  • IV Percentile 47%
  • IV Rank 19.35%
  • IV High 46.29% on 08/05/24
  • IV Low 19.76% on 08/16/24
  • Put/Call Vol Ratio 1.53
  • Today's Volume 1,391
  • Volume Avg (30-Day) 2,042
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 41,722
  • Open Int (30-Day) 42,309

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.40
  • Number of Estimates 10
  • High Estimate 1.44
  • Low Estimate 1.37
  • Prior Year 1.38
  • Growth Rate Est. (year over year) +1.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
154.32 +7.03%
on 02/18/25
177.00 -6.68%
on 03/10/25
+7.65 (+4.86%)
since 02/14/25
3-Month
154.32 +7.03%
on 02/18/25
177.40 -6.89%
on 02/06/25
-5.62 (-3.29%)
since 12/17/24
52-Week
144.80 +14.07%
on 04/22/24
200.33 -17.55%
on 09/19/24
-7.40 (-4.29%)
since 03/15/24

Most Recent Stories

More News
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

SUPN : 32.16 (+2.88%)
JNJ : 162.84 (+0.02%)
ZTS : 165.17 (+2.42%)
LLY : 824.76 (+1.39%)
PFE : 26.05 (+1.28%)
How Is Zoetis’ Stock Performance Compared to Other Pet Care Stocks?

Zoetis has notably lagged behind other pet care stocks over the past year, yet analysts remain strongly bullish on the stock’s prospects.

PAWZ : 52.97 (+2.32%)
MRK : 94.79 (+1.10%)
ZTS : 165.17 (+2.42%)
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

CORT : 57.88 (+3.34%)
RPRX : 33.02 (+0.76%)
SUPN : 32.16 (+2.88%)
OGN : 15.62 (+2.02%)
ZTS : 165.17 (+2.42%)
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

CORT : 57.88 (+3.34%)
SUPN : 32.16 (+2.88%)
MRK : 94.79 (+1.10%)
ZTS : 165.17 (+2.42%)
BMY : 59.99 (+1.66%)
Zoetis (ZTS): Buy, Sell, or Hold Post Q4 Earnings?

Zoetis (ZTS): Buy, Sell, or Hold Post Q4 Earnings?

ZTS : 165.17 (+2.42%)
Rule Breaker Investing: Pet Perks, Vol. 2

Little things can make a big difference.

NFLX : 950.02 (+3.49%)
CPRT : 53.75 (+2.09%)
AAPL : 214.00 (+0.24%)
TSLA : 238.01 (-4.79%)
SPOT : 597.46 (+3.94%)
CROX : 103.87 (+5.34%)
ZTS : 165.17 (+2.42%)
AXON : 554.82 (-0.26%)
AMZN : 195.74 (-1.12%)
WMT : 87.46 (+2.47%)
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now

It is a beautiful thing when you find a feel-good stock that offers market-beating potential. A perfect example of this combination today is animal healthcare specialist Zoetis (NYSE: ZTS) .

ZTS : 165.17 (+2.42%)
2 Healthcare Stocks with Big Upside and 1 to Skip

2 Healthcare Stocks with Big Upside and 1 to Skip

MRK : 94.79 (+1.10%)
ZTS : 165.17 (+2.42%)
REGN : 678.42 (+1.73%)
Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks

Every stock tells a story; it takes humans to find the meaning in it.

NFLX : 950.02 (+3.49%)
NVDA : 119.53 (-1.76%)
AAPL : 214.00 (+0.24%)
KO : 70.12 (+1.39%)
F : 9.92 (+1.95%)
CROX : 103.87 (+5.34%)
AXON : 554.82 (-0.26%)
BRK.TO : 39.26 (+1.63%)
NKE : 73.70 (+2.85%)
PFE : 26.05 (+1.28%)
CPRT : 53.75 (+2.09%)
COST : 916.61 (+1.40%)
Love, Money, and Stocks

In this podcast, Motley Fool host Dylan Lewis and analysts Jason Moser and Emily Flippen break down:

AAON : 82.76 (+0.75%)
ROKU : 69.65 (+2.76%)
APP : 306.85 (+4.77%)
TTD : 56.50 (+4.75%)
BROS : 61.94 (-0.86%)
ABNB : 126.94 (+3.32%)
PFE : 26.05 (+1.28%)
SHOP : 96.59 (+1.83%)
LULU : 327.09 (+5.16%)
SBUX : 99.08 (+0.99%)
ZTS : 165.17 (+2.42%)
UPST : 50.04 (+3.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 170.77
2nd Resistance Point 168.30
1st Resistance Point 166.73
Last Price 165.17
1st Support Level 162.69
2nd Support Level 160.22
3rd Support Level 158.65

See More

52-Week High 200.33
Fibonacci 61.8% 179.12
Fibonacci 50% 172.57
Fibonacci 38.2% 166.01
Last Price 165.17
52-Week Low 144.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar